Development of Hyperthyroidism during Long Term Interferon Therapy in a Patient with Chronic Myelogenous leukemia

Endocrine Journal

GÜLSÜM ÖZET¹  ZAFER ÇALISKANER¹  AHMET ÖZET¹  BEKIR ÖZTÜRK¹  SEREF KÖMÜRCܹ 

[1] Department of Medical Oncology, Gulhane Military Medical Academy

关键词: Sheep;    GH;    Volatile fatty acids;    Portal blood;   

DOI  :  10.1507/endocrj.44.715

学科分类：内分泌与代谢学

来源: Japan Endocrine Society

【 摘 要 】

References(10)Cited-By(3)In this case report a patient with thyroid dysfunction who received chronic treatment with interferon-alpha (INF-α) following a diagnosis of chronic myelogenous leukemia (CML) is described. Generally INF-α induced dysthyroidism develops in the earlier phase of INF-α treatment. This is a case report of thyroid dysfunction which occurred 4 years after the patient began to receive INF-α administration. In addition, INF-α was administered to this patient for a longer period than those reported in the literature.

【 授权许可】

Unknown